Provided By GlobeNewswire
Last update: Aug 8, 2025
FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization.
Read more at globenewswire.comNASDAQ:NTRBW (10/20/2025, 8:06:28 PM)
2.49
-0.01 (-0.4%)
NASDAQ:NTRB (10/22/2025, 4:30:01 PM)
7.04
-0.24 (-3.23%)
Find more stocks in the Stock Screener